Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator

Abstract

The blood anion nitrite contributes to hypoxic vasodilation through a heme-based, nitric oxide (NO)–generating reaction with deoxyhemoglobin and potentially other heme proteins1. We hypothesized that this biochemical reaction could be harnessed for the treatment of neonatal pulmonary hypertension, an NO-deficient state characterized by pulmonary vasoconstriction, right-to-left shunt pathophysiology and systemic hypoxemia2. To test this, we delivered inhaled sodium nitrite by aerosol to newborn lambs with hypoxic and normoxic pulmonary hypertension. Inhaled nitrite elicited a rapid and sustained reduction (65%) in hypoxia-induced pulmonary hypertension, with a magnitude approaching that of the effects of 20 p.p.m. NO gas inhalation. This reduction was associated with the immediate appearance of NO in expiratory gas. Pulmonary vasodilation elicited by aerosolized nitrite was deoxyhemoglobin- and pH-dependent and was associated with increased blood levels of iron-nitrosyl-hemoglobin. Notably, from a therapeutic standpoint, short-term delivery of nitrite dissolved in saline through nebulization produced selective, sustained pulmonary vasodilation with no clinically significant increase in blood methemoglobin levels. These data support the concept that nitrite is a vasodilator acting through conversion to NO, a process coupled to hemoglobin deoxygenation and protonation, and evince a new, simple and inexpensive potential therapy for neonatal pulmonary hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Vasodilatory effects of nitrite during hypoxia-induced pulmonary hypertension.
Figure 2: Hypoxic potentiation of nitrite-dependent vasodilation.
Figure 3: Nitric oxide formation from nitrite is potentiated by hypoxia and physiological acidosis.
Figure 4: Comparison of the physiological effects of nitrite versus inhaled NO gas.

Similar content being viewed by others

References

  1. Cosby, K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9, 1498–1505 (2003).

    Article  CAS  Google Scholar 

  2. Kinsella, J.P. & Abman, S.H. Inhaled nitric oxide: current and future uses in neonates. Semin. Perinatol. 24, 387–395 (2000).

    Article  CAS  Google Scholar 

  3. Clark, R.H. et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N. Engl. J. Med. 342, 469–474 (2000).

    Article  CAS  Google Scholar 

  4. Roberts, J.D., Jr. et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N. Engl. J. Med. 336, 605–610 (1997).

    Article  CAS  Google Scholar 

  5. Doyle, M.P., Pickering, R.A., DeWeert, T.M., Hoekstra, J.W. & Pater, D. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J. Biol. Chem. 256, 12393–12398 (1981).

    CAS  PubMed  Google Scholar 

  6. Nagababu, E., Ramasamy, S., Abernethy, D.R. & Rifkind, J.M. Active nitric oxide produced in the red cell under hypoxic conditions by deoxyhemoglobin-mediated nitrite reduction. J. Biol. Chem. 278, 46349–46356 (2003).

    Article  CAS  Google Scholar 

  7. Schreiber, M.D. et al. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N. Engl. J. Med. 349, 2099–2107 (2003).

    Article  CAS  Google Scholar 

  8. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. N. Engl. J. Med. 336, 597–604 (1997).

  9. Martin, R.J. Nitric oxide for preemies—not so fast. N. Engl. J. Med. 349, 2157–2149 (2003).

    Article  CAS  Google Scholar 

  10. Pierce, C.M., Peters, M.J., Cohen, G., Goldman, A.P. & Petros, A.J. Cost of nitric oxide is exorbitant. BMJ 325, 336 (2002).

    Article  CAS  Google Scholar 

  11. Subhedar, N.V., Jauhari, P. & Natarajan, R. Cost of inhaled nitric oxide therapy in neonates. Lancet 359, 1781–1782 (2002).

    Article  Google Scholar 

  12. Kinsella, J.P., Griebel, J., Schmidt, J.M. & Abman, S.H. Use of inhaled nitric oxide during interhospital transport of newborns with hypoxemic respiratory failure. Pediatrics 109, 158–161 (2002).

    Article  Google Scholar 

  13. Gladwin, M.T. Haldane, hot dogs, halitosis, and hypoxic vasodilation: the emerging biology of the nitrite anion. J. Clin. Invest. 113, 19–21 (2004).

    Article  CAS  Google Scholar 

  14. Furchgott, R.F. & Bhadrakom, S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J. Pharmacol. Exp. Ther. 108, 129–143 (1953).

    CAS  PubMed  Google Scholar 

  15. Ignarro, L.J. et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218, 739–749 (1981).

    CAS  PubMed  Google Scholar 

  16. Kimura, H., Mittal, C.K. & Murad, F. Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J. Biol. Chem. 250, 8016–8022 (1975).

    CAS  PubMed  Google Scholar 

  17. Lauer, T. et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc. Natl. Acad. Sci. USA 98, 12814–12819 (2001).

    Article  CAS  Google Scholar 

  18. Pawloski, J.R. Hemoglobin and nitric oxide. N. Engl. J. Med. 349, 402–5; author reply 402–405 (2003).

    Article  Google Scholar 

  19. McMahon, T.J. Hemoglobin and nitric oxide. N. Engl. J. Med. 349, 402–405; author reply 402–405 (2003).

    Article  Google Scholar 

  20. Gladwin, M.T. et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc. Natl. Acad. Sci. USA 97, 11482–11487 (2000).

    Article  CAS  Google Scholar 

  21. Zweier, J.L., Wang, P., Samouilov, A. & Kuppusamy, P. Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1, 804–809 (1995).

    Article  CAS  Google Scholar 

  22. Hunter, C.J. et al. Cerebral blood flow and oxygenation during venoarterial and venovenous extracorporeal membrane oxygenation in the newborn lamb. Pediatr. Crit. Care. Med. in the press (2004).

  23. Coates, A.L., Allen, P.D., MacNeish, C.F., Ho, S.L. & Lands, L.C. Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Chest 119, 1123–1130 (2001).

    Article  CAS  Google Scholar 

  24. Clay, M.M., Pavia, D., Newman, S.P. & Clarke, S.W. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 38, 755–759 (1983).

    Article  CAS  Google Scholar 

  25. Kinsella, J.P., Neish, S.R., Shaffer, E. & Abman, S.H. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340, 819–820 (1992).

    Article  CAS  Google Scholar 

  26. Frostell, C., Fratacci, M.D., Wain, J.C., Jones, R. & Zapol, W.M. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83, 2038–2047 (1991).

    Article  CAS  Google Scholar 

  27. Roberts, J.D., Jr. et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ. Res. 72, 246–254 (1993).

    Article  CAS  Google Scholar 

  28. Gladwin, M.T. et al. S-Nitrosohemoglobin is unstable in the reductive erythrocyte environment and lacks O2/NO-linked allosteric function. J. Biol. Chem. 277, 27818–27828 (2002).

    Article  CAS  Google Scholar 

  29. Yang, B.K., Vivas, E.X., Reiter, C.D. & Gladwin, M.T. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic. Res. 37, 1–10 (2003).

    Article  CAS  Google Scholar 

  30. Xu, X. et al. Measurements of nitric oxide on the heme iron and beta-93 thiol of human hemoglobin during cycles of oxygenation and deoxygenation. Proc. Natl. Acad. Sci. USA 100, 11303–11308 (2003).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank S. Bragg for expert technical assistance. This work was supported in part by the Clinical Center intramural funds (M.T.G.), and National Institutes of Health grants HL654941 (G.G.P.) and HL58091 (D.B.K.-S.). C.J.H. is a fellow in the Clinical Research Training Program at the National Institutes of Health supported through a grant from Pfizer Pharmaceuticals Group administered by the Foundation for the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Gordon G Power or Mark T Gladwin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hunter, C., Dejam, A., Blood, A. et al. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med 10, 1122–1127 (2004). https://doi.org/10.1038/nm1109

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1109

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing